{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:12Z","timestamp":1787020092805,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100576"],"award-info":[{"award-number":["82100576"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200605"],"award-info":[{"award-number":["82200605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04357-1","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:12:40Z","timestamp":1761739960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Histological remission as a reliable predictor of clinical outcomes in patients with ulcerative colitis after conventional therapy: a 5-year analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Tong","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"4357_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","volume":"114","author":"DT Rubin","year":"2019","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD. ACG clinical guideline: ulcerative colitis in adults. Am J Gastroenterol. 2019;114:384\u2013413.","journal-title":"Am J Gastroenterol"},{"key":"4357_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023;402:571\u201384.","journal-title":"Lancet"},{"key":"4357_CR3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1001\/jama.2023.15389","volume":"330","author":"B Gros","year":"2023","unstructured":"Gros B, Kaplan GG. Ulcerative colitis in adults: a review. JAMA. 2023;330:951\u201365.","journal-title":"JAMA"},{"key":"4357_CR4","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.14309\/ajg.0000000000003463","volume":"120","author":"DT Rubin","year":"2025","unstructured":"Rubin DT, Ananthakrishnan AN, Siegel CA, Barnes EL, Long MD. ACG clinical guideline update: ulcerative colitis in adults. Am J Gastroenterol. 2025;120:1187.","journal-title":"Am J Gastroenterol"},{"key":"4357_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41575-024-01035-7","volume":"22","author":"S Vieujean","year":"2025","unstructured":"Vieujean S, Jairath V, Peyrin-Biroulet L, Dubinsky M, Iacucci M, Magro F, et al. Understanding the therapeutic toolkit for inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2025;22:371\u201394.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4357_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40266-018-0611-x","volume":"36","author":"MP Shrestha","year":"2019","unstructured":"Shrestha MP, Taleban S. Management of ulcerative colitis in the elderly. Drugs Aging. 2019;36:13\u201327.","journal-title":"Drugs Aging"},{"key":"4357_CR7","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner D, Ricciuto A, Lewis A, D\u2019Amico F, Dhaliwal J, Griffiths AM, et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160:1570\u201383.","journal-title":"Gastroenterology"},{"key":"4357_CR8","doi-asserted-by":"crossref","unstructured":"Pai RK, D'Haens G, Kobayashi T, Sands BE, Travis S, Jairath V, et al. Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials. Expert Rev Gastroenterol Hepatol. 2024;18(1\u20133):73\u201387.","DOI":"10.1080\/17474124.2024.2326838"},{"key":"4357_CR9","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/1751-2980.12546","volume":"18","author":"D Flux\u00e1","year":"2017","unstructured":"Flux\u00e1 D, Simian D, Flores L, Ib\u00e1\u00f1ez P, Lubascher J, Figueroa C, et al. Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis. J Dig Dis. 2017;18:634\u201341.","journal-title":"J Dig Dis"},{"key":"4357_CR10","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1016\/j.cgh.2019.12.011","volume":"18","author":"RK Pai","year":"2019","unstructured":"Pai RK, Hartman DJ, Rivers CR, Regueiro M, Schwartz M, Binion DG, et al. Complete resolution of mucosal neutrophils associates with improved Long-Term clinical outcomes of patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2019;18:2510\u2013e25175.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4357_CR11","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/MIB.0b013e318280e75f","volume":"19","author":"B Lemmens","year":"2013","unstructured":"Lemmens B, Arijs I, Van Assche G, Sagaert X, Geboes K, Ferrante M, et al. Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis. Inflamm Bowel Dis. 2013;19:1194\u2013201.","journal-title":"Inflamm Bowel Dis"},{"key":"4357_CR12","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.cgh.2019.09.021","volume":"18","author":"C Ma","year":"2019","unstructured":"Ma C, Sandborn WJ, D\u2019Haens GR, Zou G, Stitt LW, Singh S, et al. Discordance between Patient-Reported outcomes and mucosal inflammation in patients with mild to moderate ulcerative colitis. Clin Gastroenterol Hepatol. 2019;18:1760\u2013e17681.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4357_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/ibd\/izaa048","volume":"27","author":"MT Osterman","year":"2021","unstructured":"Osterman MT, Scott FI, Fogt FF, Gilroy ED, Parrott S, Galanko J, et al. Endoscopic and histological assessment, correlation, and relapse in clinically quiescent ulcerative colitis (MARQUEE). Inflamm Bowel Dis. 2021;27:207\u201314.","journal-title":"Inflamm Bowel Dis"},{"key":"4357_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11113090","volume":"11","author":"AE Jucan","year":"2023","unstructured":"Jucan AE, Gavrilescu O, Dranga M, Popa IV, Mihai I-R, Mihai V-C, et al. Evaluation of disease activity in inflammatory bowel disease: diagnostic tools in the assessment of histological healing. Biomedicines. 2023;11:3090.","journal-title":"Biomedicines"},{"key":"4357_CR15","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/ajg.2016.418","volume":"111","author":"S Park","year":"2016","unstructured":"Park S, Abdi T, Gentry M, Laine L. Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: systematic review and meta-analysis. Am J Gastroenterol. 2016;111:1692\u2013701.","journal-title":"Am J Gastroenterol"},{"key":"4357_CR16","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.cgh.2017.02.016","volume":"15","author":"B Christensen","year":"2017","unstructured":"Christensen B, Hanauer SB, Erlich J, Kassim O, Gibson PR, Turner JR, et al. Histologic normalization occurs in ulcerative colitis and is associated with improved clinical outcomes. Clin Gastroenterol Hepatol. 2017;15:1557\u2013e15641.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4357_CR17","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/gutjnl-2015-309598","volume":"65","author":"RV Bryant","year":"2016","unstructured":"Bryant RV, Burger DC, Delo J, Walsh AJ, Thomas S, von Herbay A, et al. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut. 2016;65:408\u201314.","journal-title":"Gut"},{"key":"4357_CR18","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1097\/MIB.0000000000001275","volume":"23","author":"A Ponte","year":"2017","unstructured":"Ponte A, Pinho R, Fernandes S, Rodrigues A, Alberto L, Silva JC, et al. Impact of histological and endoscopic remissions on clinical recurrence and recurrence-free time in ulcerative colitis. Inflamm Bowel Dis. 2017;23:2238\u201344.","journal-title":"Inflamm Bowel Dis"},{"key":"4357_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.14309\/ajg.0000000000000437","volume":"115","author":"T Chateau","year":"2020","unstructured":"Chateau T, Feakins R, Marchal-Bressenot A, Magro F, Danese S, Peyrin-Biroulet L. Histological remission in ulcerative colitis: under the microscope is the cure. Am J Gastroenterol. 2020;115:179\u201389.","journal-title":"Am J Gastroenterol"},{"key":"4357_CR20","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625\u20139.","journal-title":"N Engl J Med"},{"key":"4357_CR21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1136\/gutjnl-2017-315545","volume":"68","author":"F Magro","year":"2019","unstructured":"Magro F, Lopes J, Borralho P, Lopes S, Coelho R, Cotter J, et al. Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels. Gut. 2019;68:594\u2013603.","journal-title":"Gut"},{"key":"4357_CR22","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","volume":"2","author":"SC Truelove","year":"1955","unstructured":"Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041\u20138.","journal-title":"Br Med J"},{"key":"4357_CR23","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1093\/ecco-jcc\/jjad106","volume":"17","author":"J Burisch","year":"2023","unstructured":"Burisch J, Safroneeva E, Laoun R, Ma C. Lack of benefit for early escalation to advanced therapies in ulcerative colitis: critical appraisal of current evidence. J Crohns Colitis. 2023;17:2002\u201311.","journal-title":"J Crohns Colitis"},{"key":"4357_CR24","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41575-024-00989-y","volume":"21","author":"C Ma","year":"2024","unstructured":"Ma C, Jairath V, Feagan BG, Peyrin-Biroulet L, Danese S, Sands BE, et al. Interpreting modern randomized controlled trials of medical therapy in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2024;21:792\u2013808.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4357_CR25","doi-asserted-by":"crossref","unstructured":"Neurath MF, Vieth M. Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing. Gut. 2023;72(11):2164\u201383.","DOI":"10.1136\/gutjnl-2023-329964"},{"key":"4357_CR26","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1053\/j.gastro.2021.02.035","volume":"160","author":"C Ma","year":"2021","unstructured":"Ma C, Sedano R, Almradi A, Vande Casteele N, Parker CE, Guizzetti L, et al. An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials. Gastroenterology. 2021;160:2291\u2013302.","journal-title":"Gastroenterology"},{"key":"4357_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/srep29239","volume":"6","author":"O Chernavskaia","year":"2016","unstructured":"Chernavskaia O, Heuke S, Vieth M, Friedrich O, Sch\u00fcrmann S, Atreya R, et al. Beyond endoscopic assessment in inflammatory bowel disease: real-time histology of disease activity by non-linear multimodal imaging. Sci Rep. 2016;6:29239.","journal-title":"Sci Rep"},{"key":"4357_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.clinre.2014.07.012","volume":"39","author":"A Tursi","year":"2015","unstructured":"Tursi A, Elisei W, Picchio M, Forti G, Penna A, Inchingolo CD, et al. Histological inflammation in ulcerative colitis in deep remission under treatment with Infliximab. Clin Res Hepatol Gastroenterol. 2015;39:107\u201313.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"4357_CR29","doi-asserted-by":"crossref","unstructured":"Rubin DT, Kubassova O, Weber CR, Adsul S, Freire M, Biedermann L, et al. Deployment of an artificial intelligence histology tool to aid qualitative assessment of histopathology using the Nancy Histopathology Index in ulcerative colitis. Inflamm Bowel Dis. 2025;31(6):1630\u20136.","DOI":"10.1093\/ibd\/izae204"},{"key":"4357_CR30","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/ecco-jcc\/jjaa110","volume":"14","author":"F Magro","year":"2020","unstructured":"Magro F, Doherty G, Peyrin-Biroulet L, Svrcek M, Borralho P, Walsh A, et al. Ecco position paper: harmonization of the approach to ulcerative colitis histopathology. J Crohns Colitis. 2020;14:1503\u201311.","journal-title":"J Crohns Colitis"},{"key":"4357_CR31","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/ecco-jcc\/jjad110","volume":"17","author":"TL Parigi","year":"2023","unstructured":"Parigi TL, Cannatelli R, Nardone OM, Zammarchi I, Shivaji U, Furfaro F, et al. Neutrophil-only histological assessment of ulcerative colitis correlates with endoscopic activity and predicts long-term outcomes in a multicentre study. J Crohns Colitis. 2023;17:1931\u20138.","journal-title":"J Crohns Colitis"},{"key":"4357_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/gutjnl-2015-310187","volume":"66","author":"A Marchal-Bressenot","year":"2017","unstructured":"Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C, Bastien C, Cahn V, Cadiot G, et al. Development and validation of the Nancy histological index for UC. Gut. 2017;66:43\u20139.","journal-title":"Gut"},{"key":"4357_CR33","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1023\/B:DDAS.0000020506.84248.f9","volume":"49","author":"IM Minderhoud","year":"2004","unstructured":"Minderhoud IM, Oldenburg B, Wismeijer JA, van Berge Henegouwen GP, Smout AJPM. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci. 2004;49:469\u201374.","journal-title":"Dig Dis Sci"},{"key":"4357_CR34","doi-asserted-by":"publisher","first-page":"674","DOI":"10.3109\/00365521.2014.898084","volume":"49","author":"N Fukuba","year":"2014","unstructured":"Fukuba N, Ishihara S, Tada Y, Oshima N, Moriyama I, Yuki T, et al. Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study. Scand J Gastroenterol. 2014;49:674\u201380.","journal-title":"Scand J Gastroenterol"},{"key":"4357_CR35","doi-asserted-by":"crossref","unstructured":"Rieder F, Mukherjee PK, Massey WJ, Wang Y, Fiocchi C. Fibrosis in IBD: from pathogenesis to therapeutic targets. Gut. 2024;73(5):854\u201366.","DOI":"10.1136\/gutjnl-2023-329963"},{"key":"4357_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/ibd\/izad159","volume":"30","author":"F D\u2019Amico","year":"2024","unstructured":"D\u2019Amico F, Magro F, Siegmund B, Kobayashi T, Kotze PG, Solitano V, et al. Disease clearance as a new outcome in ulcerative colitis: a systematic review and expert consensus. Inflamm Bowel Dis. 2024;30:1009\u201317.","journal-title":"Inflamm Bowel Dis"},{"key":"4357_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.15403\/jgld-3145","volume":"30","author":"A Tursi","year":"2021","unstructured":"Tursi A, Nenna R, Musci G, Elisei W, Picchio M. Histological remission in ulcerative colitis in deep remission under treatment with adalimumab. J Gastrointestin Liver Dis. 2021;30:55\u20138.","journal-title":"J Gastrointestin Liver Dis"},{"key":"4357_CR38","doi-asserted-by":"publisher","first-page":"10654","DOI":"10.3748\/wjg.v21.i37.10654","volume":"21","author":"A Wiernicka","year":"2015","unstructured":"Wiernicka A, Szymanska S, Cielecka-Kuszyk J, Dadalski M, Kierkus J. Histological healing after Infliximab induction therapy in children with ulcerative colitis. World J Gastroenterol. 2015;21:10654\u201361.","journal-title":"World J Gastroenterol"},{"key":"4357_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s40265-016-0676-y","volume":"77","author":"P Boal Carvalho","year":"2017","unstructured":"Boal Carvalho P, Cotter J. Mucosal healing in ulcerative colitis: a comprehensive review. Drugs. 2017;77:159\u201373.","journal-title":"Drugs"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04357-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04357-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04357-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:12:42Z","timestamp":1761739962000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04357-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4357"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04357-1","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that all procedures involving human participants were performed in accordance with the ethical standards of the relevant institutional and national research committees, as well as with the 1964 Helsinki Declaration and its later amendments (2008). This study was approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University (Number of approval: [2024]392), and a waiver of informed consent was granted for this retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"771"}}